Advertisements


Sanofi Eczema Drug Dupixent Succeeds in Adolescents Study

Sanofi (SNY) announces positive results from a phase III study evaluating Dupixent for the treatment of moderate-to-severe atopic dermatiti.....»»

Category: personnelSource: nytMay 16th, 2018

The Wall Street Journal: Experimental peanut-allergy drug shows encouraging results in protecting kids

An experimental drug derived from peanuts protected some children and adolescents with life-threatening peanut allergies, according to a study, allowing the subjects to eat small amounts of peanuts without suffering a serious reaction......»»

Category: topSource: marketwatchNov 18th, 2018

AbbVie"s HCV Drug Mavyret Succeeds in Label Expansion Study

Zacks.....»»

Category: topSource: redinewsNov 14th, 2018

AbbVie"s HCV Drug Mavyret Succeeds in Label Expansion Study

AbbVie's (ABBV) Mavyret demonstrates high virologic cure rates in a study evaluating .....»»

Category: worldSource: nytNov 14th, 2018

Drug succeeds in arthritis study, Gilead stock jumps

A new drug meant to help rheumatoid arthritis achieved .....»»

Category: topSource: marketwatchSep 11th, 2018

Glaxo, J&J"s Dual Drug HIV Regimen Succeeds in Phase III Study

Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV. GlaxoSmithKline’s GSK HIV drug subsidiary-ViiV H.....»»

Category: smallbizSource: nytAug 17th, 2018

Merck"s Keytruda Improves Survival in Head/Neck Cancer Study

Merck's (MRK) key cancer drug Keytruda succeeds as a monotherapy in phas.....»»

Category: worldSource: nytJul 25th, 2018

Pfizer"s Epilepsy Drug Lyrica Succeeds in Pediatric Study

Zacks.....»»

Category: topSource: redinewsMay 19th, 2018

Latino, African-American adolescents less likely to have undiagnosed asthma, study finds

Although there are known health care disparities and shortages that impact Latino and African-American adolescents in urban areas, the two groups were found to be at lower risk for undiagnosed asthma... To view the full story, click the title link......»»

Category: blogSource: crainsnewyork14 hr. 26 min. ago

The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 8) read more.....»»

Category: blogSource: benzingaJan 9th, 2019

Aerie"s Rhopressa Succeeds in Study on Japanese Patients

Zacks.....»»

Category: topSource: redinewsJan 7th, 2019

Pill for postpartum depression by Cambridge"s Sage succeeds in late-stage trial

Sage Therapeutics, one of Cambridge's largest biotech firms, today reported that its pill to treat postpartum depression appears to have succeeded in a late-stage trial. In a study of 151 women suffering from the condition, those who were given ora.....»»

Category: topSource: bizjournalsJan 7th, 2019

Biogen Begins Improved Dosing Regimen on Tysabri in Phase III

Biogen (BIIB) commences enrollment in late-stage study to evaluate an expanded interval dosing of its MS drug.....»»

Category: personnelSource: nytJan 4th, 2019

Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study

Zacks.....»»

Category: topSource: redinewsDec 21st, 2018

G1 Therapeutics stock dives on cancer-related infection drug study results

G1 Therapeutics Inc. shares dropped in the extended session Wednesday after the biotech drug maker said one of its drugs met endpoints i.....»»

Category: topSource: marketwatchDec 19th, 2018

Vertex"s (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint

Vertex (VRTX) reports positive phase II data of its pipeline candidate VX-150 in patients with pain caused by small fiber neuropathy. .....»»

Category: personnelSource: nytDec 19th, 2018

Retail workers tested positive for drugs at the highest rate last year, Quest study shows

Retail had highest rate of positive drug tests in 2017 as more employers waive screening in the tight labor market. He.....»»

Category: topSource: usatodayDec 19th, 2018

Evofem Shares Up as Birth Control Gel Succeeds in Phase III

Evofem (EVFM) stock surges on positive results from a late-stage study on experimental birt.....»»

Category: dealsSource: nytDec 18th, 2018

Puma Bio stock rises more than 9% on drug study

Shares of Puma Biotechnology Inc. rose more than 9% in the extended session Mo.....»»

Category: topSource: marketwatchDec 17th, 2018

Teen Vaping Is on the Rise, While Other Drug Use Declines

More teens are vaping than ever before, study finds. More American teenagers are vaping, while their use of alcohol, cigarettes, cocaine, LSD, ecstasy, heroin, and opioid pills is dropping, according to University of Michigan .....»»

Category: europeSource: fortuneDec 17th, 2018

Neurocrine Biosciences says trial of Tourette syndrome treatment missed primary goal

Neurocrine Biosciences Inc. said Wednesday a midstage trial of a treatment for Tourette syndrome in children and adolescents failed to meet its primary goal. The Phase IIb study found valbenazine did not meet the primary endpoint of reducing tic .....»»

Category: topSource: marketwatchDec 12th, 2018